References
- Christiaens TC, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 2002;52:729–34.
- Hummers-Pradier E, Kochen MM. Urinary tract infections in adult general practice patients. Br J Gen Pract 2002;52:752–61.
- Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999;29:745–58.
- Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection? JAMA 2002;287:2701–10.
- Huppert JS, Biro F, Lan D, Mortensen JE, Reed J, Slap GB. Urinary symptoms in adolescent females: STI or UTI? J Adolesc Health 2007;40:418–24.
- Nickel JC. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis. Curr Opin Urol 2006;16:5–10.
- Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002;113(Suppl 1A); 14S–19S.
- Melekos MD, Naber KG. Complicated urinary tract infections. Int J Antimicrob Agents 2000;15:247–56.
- Moreno E, Andreu A, Pigrau C, Kuskowski MA, Johnson JR, Prats G. Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol 2008;46;2529–34.
- Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO·SENS Project. J Antimicrob Chemother 2003;51:69–76.
- Söderblom T, Struwe J. Extended spectrum beta-lactamase-producing Enterobacteriaceae: the first six months of notifications according to the Swedish communicable disease act. Euro Surveillance 2007;12:3290.
- Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008;13. pii: 19044.
- Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, . CTX-M: Changing the face of ESBLs in Europe. J Antimicrob Chemother 2007;59:165–74.
- Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chem-other 2005;56;52–9.
- Rodrigues-Bano , Lopez-Cerero , Navarro MD, Diaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008;62;1142–9.
- Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004;42:4769–75.
- Arpin C, Quentin C, Grobost F, Cambau E, Robert J, Dubois V, Scientific Committee of ONERBA. Nationwide survey of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the French community setting. J Anti-microb Chemother 2009;63:1205–14.
- Fang H, Lundberg C, Olsson-Liljequist B, Hedin G, LindbÄck E, Rosenberg Å, . Molecular epidemiological analysis of Escherichia coli isolates producing extended spectrum beta-lactamases for identification of nosocomial outbreaks in Stockholm, Sweden. J Clin Microbiol 2004;42:5917–20.
- Lytsy B, Sandegren L, Tano E, Torell E, Andersson Dan I, Melhus Å. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 2008;116:302–8.
- Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical microbiology. Ninth ed. Washington DC: ASM Press; 2007.
- Jeong SH, Bae IK, Lee JH, Sohn SG, Kang GH, Jeon GJ, . Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneu-moniae and Escherichia coli from a Korean nationwide survey. J Clin Microbiol 2004;42;2902–6.
- Swedish Institute for Infectious Disease Control. Statistics for extended-spectrum beta-lactamase (ESBL) 2007. Available (accessed November 2009).
- SWEDRES 2007. A report on Swedish antimicrobial utilisation and resistance in human medicine. (accessed November 2009).
- Hummers-Pradier E, Ohse AM, Koch M, Heizmann WR, Kochen MM. Management of urinary tract infection in female general practice patients. Fam Pract 2005;22:71–7.
- Nys S, van Merode T, Bartelds AI, Stobberingh EE. Urinary tract infection in general practice patients: diagnostic tests versus bacteriological culture. J Antimicrob Chemother 2006;57:955–8.